These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23982272)

  • 1. Multiple sclerosis is primarily a neurodegenerative disease.
    Chaudhuri A
    J Neural Transm (Vienna); 2013 Oct; 120(10):1463-6. PubMed ID: 23982272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multiple sclerosis: from the immune system to inflammatory demyelination and irreversible neurodegeneration].
    Sindic CJ
    Bull Mem Acad R Med Belg; 2002; 157(7-9):391-8; discussion 398-400. PubMed ID: 12647378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis.
    Ouellette R; Treaba CA; Granberg T; Herranz E; Barletta V; Mehndiratta A; De Leener B; Tauhid S; Yousuf F; Dupont SM; Klawiter EC; Sloane JA; Bakshi R; Cohen-Adad J; Mainero C
    Brain; 2020 Oct; 143(10):2973-2987. PubMed ID: 32935834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis: an immune or neurodegenerative disorder?
    Trapp BD; Nave KA
    Annu Rev Neurosci; 2008; 31():247-69. PubMed ID: 18558855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroprotection in the treatment of multiple sclerosis].
    Zipp F; Gold R
    Nervenarzt; 2011 Aug; 82(8):973-7. PubMed ID: 21761185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies to prevent neurodegeneration and promote regeneration in multiple sclerosis.
    Chitnis T; Imitola J; Khoury SJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Mar; 5(1):11-26. PubMed ID: 15777201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunity and neurodegeneration: new concepts in multiple sclerosis].
    Lalive PH; Schluep M; Chofflon M; Du Pasquier R
    Rev Med Suisse; 2006 May; 2(64):1166-8, 1170. PubMed ID: 16734188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
    Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
    Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New concepts on progressive multiple sclerosis.
    Lassmann H
    Curr Neurol Neurosci Rep; 2007 May; 7(3):239-44. PubMed ID: 17488590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis.
    Bross M; Hackett M; Bernitsas E
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.
    Filippi M; Rocca MA
    J Neurol; 2005 Nov; 252 Suppl 5():v16-24. PubMed ID: 16254697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases.
    Stolp HB; Dziegielewska KM
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):132-46. PubMed ID: 19077110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cortical gray matter lesions in multiple sclerosis].
    Kawachi I; Nishizawa M
    Brain Nerve; 2015 Apr; 67(4):497-504. PubMed ID: 25846598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunopathology of multiple sclerosis].
    Quintana FJ; Pérez-Sánchez S; Farez MF
    Medicina (B Aires); 2014; 74(5):404-10. PubMed ID: 25347906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms.
    Nijeholt GJ; van Walderveen MA; Castelijns JA; van Waesberghe JH; Polman C; Scheltens P; Rosier PF; Jongen PJ; Barkhof F
    Brain; 1998 Apr; 121 ( Pt 4)():687-97. PubMed ID: 9577394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in understanding and treating neuroinflammation.
    Infante-Duarte C; Waiczies S; Wuerfel J; Zipp F
    J Mol Med (Berl); 2008 Sep; 86(9):975-85. PubMed ID: 18196212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord.
    Kearney H; Yiannakas MC; Samson RS; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    Brain; 2014 Sep; 137(Pt 9):2456-68. PubMed ID: 24966048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human brain atlas-based multimodal MRI analysis of volumetry, diffusimetry, relaxometry and lesion distribution in multiple sclerosis patients and healthy adult controls: implications for understanding the pathogenesis of multiple sclerosis and consolidation of quantitative MRI results in MS.
    Hasan KM; Walimuni IS; Abid H; Datta S; Wolinsky JS; Narayana PA
    J Neurol Sci; 2012 Feb; 313(1-2):99-109. PubMed ID: 21978603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
    Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
    Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies and neurodegeneration in multiple sclerosis.
    Vyshkina T; Kalman B
    Lab Invest; 2008 Aug; 88(8):796-807. PubMed ID: 18521063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.